Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan.
Takeyama Y, Ono N, Shirahama Y, Inoue Y, Tanaka A, Ueda N, Nishimura N, Nagano S, Uchino A, Miyamura T, Oryoji K, Inoue H, Maruyama A, Ota SI, Yoshizawa S, Sawabe T, Himuro N, Miyake K, Kimoto Y, Horiuchi T, Mitoma H, Niiro H, Takamori A, Tada Y. Takeyama Y, et al. Among authors: sawabe t. Mod Rheumatol. 2021 Mar;31(2):408-416. doi: 10.1080/14397595.2020.1790778. Epub 2020 Jul 27. Mod Rheumatol. 2021. PMID: 32615836
Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
Otsuka Y, Kiyohara C, Kashiwado Y, Sawabe T, Nagano S, Kimoto Y, Ayano M, Mitoma H, Akahoshi M, Arinobu Y, Niiro H, Akashi K, Horiuchi T. Otsuka Y, et al. Among authors: sawabe t. PLoS One. 2018 Apr 25;13(4):e0196368. doi: 10.1371/journal.pone.0196368. eCollection 2018. PLoS One. 2018. PMID: 29694426 Free PMC article.
Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Harada T, Iwasaki H, Muta T, Urata S, Sakamoto A, Kohno K, Takase K, Miyamura T, Sawabe T, Asaoku H, Oryoji K, Fujisaki T, Mori Y, Yoshimoto G, Ayano M, Mitoma H, Miyamoto T, Niiro H, Yamamoto H, Oshiro Y, Miyoshi H, Ohshima K, Takeshita M, Akashi K, Kato K. Harada T, et al. Among authors: sawabe t. Br J Haematol. 2021 Jul;194(1):101-110. doi: 10.1111/bjh.17456. Epub 2021 Apr 6. Br J Haematol. 2021. PMID: 33822354
Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.
Kojima T, Horiuchi T, Nishizaka H, Sawabe T, Higuchi M, Harashima SI, Yoshizawa S, Tsukamoto H, Nagasawa K, Niho Y. Kojima T, et al. Among authors: sawabe t. Arthritis Rheum. 2000 Jan;43(1):135-9. doi: 10.1002/1529-0131(200001)43:1<135::AID-ANR17>3.0.CO;2-Q. Arthritis Rheum. 2000. PMID: 10643709 Free article.
Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
Sawabe T, Horiuchi T, Koga R, Tsukamoto H, Kojima T, Harashima S, Kikuchi Y, Otsuka J, Mitoma H, Yoshizawa S, Niho Y, Watanabe T. Sawabe T, et al. Genes Immun. 2003 Mar;4(2):122-31. doi: 10.1038/sj.gene.6363932. Genes Immun. 2003. PMID: 12618860
Molecular analysis of a novel hereditary C3 deficiency with systemic lupus erythematosus.
Tsukamoto H, Horiuchi T, Kokuba H, Nagae S, Nishizaka H, Sawabe T, Harashima S, Himeji D, Koyama T, Otsuka J, Mitoma H, Kimoto Y, Hashimura C, Kitano E, Kitamura H, Furue M, Harada M. Tsukamoto H, et al. Among authors: sawabe t. Biochem Biophys Res Commun. 2005 Apr 29;330(1):298-304. doi: 10.1016/j.bbrc.2005.02.159. Biochem Biophys Res Commun. 2005. PMID: 15781264
195 results